MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.160
-0.020 (-1.69%)
At close: Feb 13, 2026, 4:00 PM EST
1.200
+0.040 (3.45%)
After-hours: Feb 13, 2026, 7:53 PM EST

MIRA Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
491916---
Market Cap Growth
132.79%21.65%----
Enterprise Value
411510---
Last Close Price
1.161.141.05---
PB Ratio
6.078.583.55---
P/TBV Ratio
6.438.583.55---
Debt / Equity Ratio
--0.00-0.820.13-1.32
Net Debt / Equity Ratio
-1.00-1.29-1.05-0.23-1.11-1.27
Quick Ratio
89.793.928.270.262.570.04
Current Ratio
90.533.998.710.362.660.04
Return on Equity (ROE)
-123.33%-238.90%-634.30%-847.77%-198.47%-
Return on Assets (ROA)
-74.64%-127.59%-184.05%-209.10%-79.65%-
Return on Capital Employed (ROCE)
-94.10%-364.50%-194.90%1376.60%-95.20%298.40%
Earnings Yield
-58.50%-41.59%-77.21%---
Buyback Yield / Dilution
-17.53%-10.91%20.73%-38.60%--
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q